Table 2 Multivariable analysis of the Yonsei cohort.
From: Development and validation of a prognostic and predictive 32-gene signature for gastric cancer
Characteristics | Hazard ratio (95% CI) | P valuea |
|---|---|---|
Age | ||
≤60 years | Reference | |
>60 years | 1.95 (1.51, 2.51) | <0.001 |
Stage | ||
I | Reference | |
II | 1.86 (0.66, 5.25) | 0.241 |
III | 3.58 (1.31, 9.75) | 0.013 |
IV | 18.2 (6.08, 54.5) | <0.001 |
Tumor location | ||
Antrum | Reference | |
Body | 1.02 (0.78, 1.34) | 0.871 |
Cardia | 0.90 (0.56, 1.45) | 0.671 |
Whole | 1.49 (0.60, 3.72) | 0.395 |
Lauren type | ||
Diffuse | Reference | |
Intestinal | 0.89 (0.65, 1.22) | 0.481 |
Mixed | 0.71 (0.35, 1.42) | 0.332 |
Other | 1.20 (0.86, 1.68) | 0.294 |
Perineural invasion | ||
Negative | Reference | |
Positive | 1.12 (0.81, 1.55) | 0.491 |
Molecular subtype | ||
Group 1 | Reference | |
Group 2 | 1.97 (1.31, 2.95) | 0.001 |
Group 3 | 1.73 (1.12, 2.65) | 0.013 |
Group 4 | 2.18 (1.44, 3.31) | <0.001 |
